<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./10_1101_2020_01_30_927574v1/results/search/disease/results.xml">
  <result pre="public health emergencies. Based on our molecular insight that the" exact="hepatitis" post="C virus and the coronavirus use a similar viral"/>
  <result pre="that the FDA-approved drug EPCLUSA (Sofosbuvir/Velpatasvir) for the treatment of" exact="hepatitis" post="C will also inhibit the above coronaviruses, including 2019-nCoV."/>
  <result pre="thus share properties with other single-stranded RNA viruses such as" exact="hepatitis" post="C virus, West Nile virus, Marburg virus, HIV virus,"/>
  <result pre="drug EPCLUSA), to inhibit the RNA-dependent RNA polymerase of the" exact="hepatitis" post="C virus. Sofosbuvir, a pyrimidine nucleotide analogue ( Fig."/>
  <result pre="in vivo. From https://en.wikipedia.org/wiki/Sofosbuvir. Based on our insight that the" exact="hepatitis" post="C virus and the coronavirus use a similar viral"/>
  <result pre="reasoned that the FDA-approved drug EPCLUSA for the treatment of" exact="hepatitis" post="C will also inhibit coronaviruses, including 2019-nCoV and those"/>
  <result pre="of a β-D-2’-Deoxy-2’-α-fluoro-2’-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of" exact="hepatitis" post="C virus. J Med Chem 53: 7202– 7218. OpenUrl"/>
  <result pre="Research Team ( 2020) A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019. N Eng J Med. DOI: 10.1056/NEJMoa2001017."/>
 </snippets>
</snippetsTree>
